See the DrugPatentWatch profile for Adlyxin
What is the Adlyxin brand name (and how it may appear differently)?
Adlyxin is the brand name for lixisenatide, a GLP-1 receptor agonist used for type 2 diabetes. The same medicine can show up under different “brand name variations” depending on country labeling and how the name is written on prescriptions, pharmacy systems, or packaging.
Common brand-name spellings and formatting users may see
People often search for variations because the name may be displayed with different capitalization, spacing, or character formatting, such as:
- Adlyxin
- ADLYXIN
- Adlyxin 10 mcg / 20 mcg (strength shown alongside the brand)
- Adlyxin injection (generic product description appended)
Could “Adlyxin” be confused with other similar drug names?
Because GLP-1 drugs have many similar-sounding names, searches sometimes bring up near matches (not the same drug), such as other brand names in the same therapeutic area. If you’re trying to confirm whether a label refers to lixisenatide specifically, the key is usually the active ingredient: lixisenatide rather than just the brand text.
How to confirm you have the exact Adlyxin product
On a prescription label, box, or pharmacy record, verify:
- Active ingredient: lixisenatide
- Dose/strength: may be written with the brand name (e.g., “Adlyxin” followed by dose)
- Formulation: “injection” is commonly appended
If you share what exact wording you’re seeing (for example, a country label, strength, or the full line from a prescription), I can help identify whether it’s a true Adlyxin variation or a different GLP-1 product.
Sources
No external sources were provided with your question.